High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) StudyJing Zhang, Loki Natarajan, Tobias Fuhrer et al.|American Journal of Nephrology|2022Cited by 42
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetesHongyan Liu, David Z.I. Cherney, Vikas S. Sridhar et al.|Diabetes Obesity and Metabolism|2021Cited by 32
Individualized and Technology-Assisted Ketogenic Diet on Metabolic and Kidney Health in Overweight or Obese AdultsChristiane Meireles, Kumar Sharma, Yan Du et al.|Journal of the American Society of Nephrology|2022Cited by 1
A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) StudyBrian Kwan, Loki Natarajan, Tobias Fuhrer et al.|BMC Bioinformatics|2023Cited by 0
Empagliflozin Is Associated with Increased Plasma Lipid Metabolites in Type 1 DiabetesHongyan Liu, David Z.I. Cherney, Leif Erik Lovblom et al.|Journal of the American Society of Nephrology|2020Cited by 0